Presentations
Monday 4th September 2017
Session 1
ACST-2 Update - Alison Halliday & Richard Bulbulia
Aiming for complete data - Alison Clarke & Wojciech Brudlo
MRI Sub-study - Leo Bonati & Mandy Műller
Volume of infarcts and procedural risk - Rodolfo Pini
Session 2
Results from Swedish Carotid Registry Studies: What should we believe? - Peter Gillgren & Anders Gottsäter
Worldwide burden of stroke in the Global Burden of Disease Study - Derrick Bennett
30,000 patients randomised to HDL-raising therapy vs placebo: REVEAL revealed - Louise Bowman
Pre-dinner talk - Richard Peto
Tuesday 5th September 2017
Session 3
Dementia and vascular disease - Sarah Pendlebury
Long-term follow-up of ACST-1 - Mary Sneade & Rebecca Llewellyn-Bennett
Italian Innovation: Membrane mesh covered stents have a bright future - the iron-guard study - Laura Capoccia
Italian innovation: Proximal protection device: Mo.Ma. - Antonio Lauricella
Domenico Angiletta
Larissa registry of CAS and CEA - Konstantinos Spanos & Athanasios Giannoukas
Session 4
ECST-2 and ACTRIS Update - Leo Bonati
CREST-2 Update - Kevin M Barrett
Efforts put into ACST-2 recruitment – why patients were NOT randomised for the trial - Barbara Rantner
Recruitment! - Alison Halliday & Richard Bulbulia